NUTRA PHARMA CORP. Derivative, Fair Value, Net
NUTRA PHARMA CORP. (NPHC) had Derivative, Fair Value, Net of $2.04 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes
us-gaap:DerivativeFairValueOfDerivativeNet · last filed 2026-08-19
- 2026-06-30: Derivative, Fair Value, Net $2.04M.
- 2026-03-31: Derivative, Fair Value, Net $983.95K.
- 2025-12-31: Derivative, Fair Value, Net $960.38K.
- 2025-09-30: Derivative, Fair Value, Net $929.33K.
| Period end | Derivative, Fair Value, Net | Derivative, Fair Value, Net as first filed |
|---|---|---|
| 2026-06-30 | $2.04M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $983.95K 10-Q · filed 2026-05-29 | |
| 2025-12-31 | $960.38K 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $929.33K 10-Q · filed 2026-04-06 | |
| 2025-06-30 | $924.52K 10-Q · filed 2026-03-25 | |
| 2025-03-31 | $1.67M 10-Q · filed 2026-03-11 | |
| 2024-12-31 | $708.12K 10-K · filed 2026-05-20 | |
| 2024-09-30 | $697.22K 10-Q · filed 2026-01-02 | |
| 2024-06-30 | $697.97K 10-Q · filed 2025-12-23 | |
| 2024-03-31 | $685.05K 10-Q · filed 2025-12-17 | |
| 2023-12-31 | $661.26K 10-K · filed 2026-02-17 | |
| 2023-09-30 | $644.16K 10-Q · filed 2025-10-28 | |
| 2023-06-30 | $636.46K 10-Q · filed 2025-10-23 | |
| 2023-03-31 | $636.29K 10-Q · filed 2025-10-16 | |
| 2022-12-31 | $623.51K 10-K · filed 2025-11-24 | |
| 2022-09-30 | $4.90M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $5.01M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $5.70M 10-Q · filed 2022-05-20 | |
| 2021-12-31 | $9.83M 10-K · filed 2025-09-03 | |
| 2021-09-30 | $12.42M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $25.95M 10-Q · filed 2021-09-24 | |
| 2021-03-31 | $9.83M 10-Q · filed 2022-05-20 | $28.22M 10-Q · filed 2021-09-17 |
| 2020-12-31 | $3.38M 10-K · filed 2022-04-15 | |
| 2020-09-30 | $1.24M 10-Q · filed 2021-08-12 | |
| 2020-06-30 | $1.34M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $1.15M 10-Q · filed 2021-07-23 | |
| 2019-12-31 | $834.46K 10-K · filed 2021-09-08 |